Phreesia, Inc. (0A23.L)
USD 28.5
(-1.96%)
USD 28.5
(-1.96%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -136.88 Million USD | 22.29% |
| 2023 | -176.14 Million USD | -49.07% |
| 2022 | -118.16 Million USD | -332.95% |
| 2021 | -27.29 Million USD | -34.49% |
| 2020 | -20.29 Million USD | -34.73% |
| 2019 | -15.06 Million USD | 17.21% |
| 2018 | -18.19 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -37.53 Million USD | 1.29% |
| 2024 FY | -136.88 Million USD | 22.29% |
| 2024 Q2 | -36.76 Million USD | 2.04% |
| 2024 Q3 | -31.94 Million USD | 13.13% |
| 2024 Q4 | -30.64 Million USD | 4.05% |
| 2023 Q2 | -46.71 Million USD | 8.83% |
| 2023 FY | -176.14 Million USD | -49.07% |
| 2023 Q4 | -38.02 Million USD | 5.34% |
| 2023 Q3 | -40.16 Million USD | 14.02% |
| 2023 Q1 | -51.24 Million USD | -10.31% |
| 2022 Q1 | -10.97 Million USD | -35.55% |
| 2022 Q2 | -24.39 Million USD | -122.28% |
| 2022 Q3 | -36.34 Million USD | -48.99% |
| 2022 Q4 | -46.45 Million USD | -27.81% |
| 2022 FY | -118.16 Million USD | -332.95% |
| 2021 Q4 | -8.09 Million USD | -20.6% |
| 2021 Q3 | -6.71 Million USD | -5.37% |
| 2021 Q2 | -6.37 Million USD | -4.24% |
| 2021 FY | -27.29 Million USD | -34.49% |
| 2021 Q1 | -6.11 Million USD | -66.63% |
| 2020 Q1 | -6.69 Million USD | -31.81% |
| 2020 FY | -20.29 Million USD | -34.73% |
| 2020 Q3 | -2.43 Million USD | 67.48% |
| 2020 Q4 | -3.66 Million USD | -50.51% |
| 2020 Q2 | -7.49 Million USD | -11.93% |
| 2019 Q2 | -2.58 Million USD | 19.75% |
| 2019 Q1 | -3.22 Million USD | 0.0% |
| 2019 Q3 | -4.17 Million USD | -61.27% |
| 2019 FY | -15.06 Million USD | 17.21% |
| 2019 Q4 | -5.07 Million USD | -21.74% |
| 2018 FY | -18.19 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accuray Incorporated | -15.54 Million USD | -780.573% |
| Align Technology, Inc. | 445.05 Million USD | 130.757% |
| Elevance Health Inc. | 5.98 Billion USD | 102.286% |
| AxoGen, Inc. | -21.71 Million USD | -530.342% |
| Boston Scientific Corporation | 1.59 Billion USD | 108.593% |
| CVS Health Corporation | 8.34 Billion USD | 101.641% |
| Cardinal Health, Inc. | 852 Million USD | 116.066% |
| Centene Corporation | 2.7 Billion USD | 105.066% |
| DaVita Inc. | 691.53 Million USD | 119.794% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 102.611% |
| Hologic, Inc. | 789.5 Million USD | 117.338% |
| Humana Inc. | 2.48 Billion USD | 105.5% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 116.199% |
| Laboratory Corporation of America Holdings | 418 Million USD | 132.748% |
| Masimo Corporation | 81.5 Million USD | 267.957% |
| McKesson Corporation | 3 Billion USD | 104.56% |
| Patterson Companies, Inc. | 185.93 Million USD | 173.621% |
| Quest Diagnostics Incorporated | 854 Million USD | 116.029% |
| ResMed Inc. | 1.02 Billion USD | 113.408% |
| Henry Schein, Inc. | 416 Million USD | 132.905% |
| Teladoc Health, Inc. | -220.36 Million USD | 37.883% |
| Universal Health Services, Inc. | 717.79 Million USD | 119.07% |
| Veeva Systems Inc. | 525.7 Million USD | 126.038% |
| Baxter International Inc. | 2.65 Billion USD | 105.154% |
| Becton, Dickinson and Company | 1.48 Billion USD | 109.224% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 107.613% |
| Danaher Corporation | 4.2 Billion USD | 103.259% |
| Stryker Corporation | 3.16 Billion USD | 104.325% |
| Medtronic plc | 3.67 Billion USD | 103.724% |